Stereotatic radiotherapy

PROCEDURE2 trials

Sponsors

Belfast Health and Social Care Trust, Rigshospitalet, Denmark

Conditions

CholangiocarcinomaProstate Cancer

Unknown Phase

SPORT High-Risk Trial Evaluating SABR in Prostate Cancer

Active, not recruitingNCT03253978

Belfast Health and Social Care TrustProstate Cancer

Start: 2016-01-18End: 2026-04-30Updated: 2023-09-07

Prognostic Factors for Survival in Patients With Cholangiocarcinoma

RecruitingNCT06369480

Rigshospitalet, DenmarkCholangiocarcinoma

Start: 2024-02-01End: 2024-08-31Target: 2000Updated: 2024-04-17

Related Papers

The stereotactic prostate radiotherapy (SPORT) trial: A randomized feasibility study comparing prostate SABR to prostate and pelvic nodal SABR.

Journal of Clinical Oncology2021-02-203 citations

Plasma citrulline levels as a biomarker for bowel toxicity in prostate stereotactic radiotherapy with or without pelvic nodal radiation.

Journal of Clinical Oncology2019-03-01